Home > Jesse Pelletier – The Role of Povidone-iodine in COVID-19

Jesse Pelletier – The Role of Povidone-iodine in COVID-19

Published Online: August 6th 2020

Jesse Pelletier (Ocean Ophthalmology Group, North Miami Beach, FL, USA) discusses the role of the antiseptic povidone-iodine (PVP-I), which is now routinely employed and will play a greater role in the future of healthcare, particularly in the COVID-19 era.


1. Tell us about infection control in your office during this pandemic and where povidone-iodine (PVP-I) fits in?
2. What is the rationale behind PVP-I utilization in the nose and mouth?
3. Can you simply dilute “stock” PVP-I and use it?
4. Are these strategies broadly applicable to other specialties across medicine?

Disclosure: Jesse Pelletier is co-founder of Veloce BioPharma and Halodine, LLC.

touchOPHTHALMOLOGY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Commissioned, edited and funded by Touch Medical Media
Published: 6 August 2020

Share this Video
Related Videos In COVID-19
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar